Human papillomavirus vaccination: Ongoing challenges and future directions

被引:39
作者
Dilley, Sarah [1 ]
Miller, Kathryn M. [2 ]
Huh, Warner K. [1 ]
机构
[1] Div Gynecol Oncol, Birmingham, AL USA
[2] Dept Obstet & Gynecol, Birmingham, AL USA
基金
美国国家卫生研究院;
关键词
ADVISORY-COMMITTEE; 2-DOSE SCHEDULE; UNITED-STATES; HPV VACCINE; RECOMMENDATIONS; IMMUNOGENICITY; SAFETY; PROGRAMS; WOMEN;
D O I
10.1016/j.ygyno.2019.10.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies with prophylactic HPV vaccination have demonstrated impressive efficacy, immunogenicity, and safety results; however, the implementation and uptake in both low and high-income countries continues to be challenging. Since 2006, administration guidelines have undergone multiple updates regarding age, dosing schedule, and gender. Despite these changes, the basic tenet remains the same: prioritize immunization before initiation of sexual activity and subsequent exposure to HPV. The importance of immunizing males and females equally and the role for catch-up vaccination in late adolescent and adulthood has also been supported by subsequent research. Very recently, the FDA approved to expand the range of eligible patients for the nonavalent (9vHPV) vaccine to women and men from age 27 to 45 for the prevention of HPV-related cancers and diseases. Furthermore, members of the ACIP voted to recommend that individuals between ages 27 and 45 who have not yet been vaccinated discuss the option with their physician. This review will highlight the history of the vaccine, barriers to vaccination, current recommendations, and future directions for success. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:498 / 502
页数:5
相关论文
共 50 条
  • [21] Human papillomavirus vaccination and cervical cancer risk
    Rahangdale, Lisa
    Mungo, Chemtai
    O'Connor, Siobhan
    Chibwesha, Carla J.
    Brewer, Noel
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [22] Impact of Human Papillomavirus Vaccination in Reducing Cancer
    Khan, Mina S.
    Savoy, Margot
    [J]. PRIMARY CARE, 2020, 47 (03): : 529 - 537
  • [23] Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program
    Gichane, Margaret W.
    Calo, William A.
    McCarthy, Schatzi H.
    Walmer, Kathy A.
    Boggan, Joel C.
    Brewer, Noel T.
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2017, 30 (01) : 96 - 101
  • [24] Human Papillomavirus Infection and Vaccination
    Valentino, Katie
    Poronsky, Cathlin B.
    [J]. JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2016, 31 (02): : E155 - E166
  • [25] Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties
    Staras, Stephanie A. S.
    Huo, Tianyao
    Rothbard, Sarah M.
    Hall, Jaclyn M.
    Cho, Hee D.
    Guo, Yi
    Richardson, Eric
    Salloum, Ramzi G.
    Thompson, Lindsay A.
    Silver, Natalie L.
    Shenkman, Elizabeth A.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (06) : 812 - 820
  • [26] Current status and future directions for the development of human papillomavirus vaccines
    Wang, Rui
    Huang, Hongpeng
    Yu, Chulin
    Li, Xuefeng
    Wang, Yang
    Xie, Liangzhi
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [27] Challenges of hesitancy in human papillomavirus vaccination: Bibliometric and visual analysis
    Deng, Disi
    Shen, Yifeng
    Li, Wanjing
    Zeng, Nan
    Huang, Yefang
    Nie, Xiaowei
    [J]. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2023, 38 (05) : 1161 - 1183
  • [28] Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
    Kim, Jane J.
    Simms, Kate T.
    Killen, James
    Smith, Megan A.
    Burger, Emily A.
    Sy, Stephen
    Regan, Catherine
    Canfell, Karen
    [J]. PLOS MEDICINE, 2021, 18 (03)
  • [29] Human papillomavirus vaccination in HIV-infected women: need for increased coverage
    Kojic, Erna Milunka
    Rana, Aadia I.
    Cu-Uvin, Susan
    [J]. EXPERT REVIEW OF VACCINES, 2016, 15 (01) : 105 - 117
  • [30] American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention
    Bailey, Howard H. t
    Chuang, Linus T.
    duPont, Nefertiti C.
    Eng, Cathy
    Foxhall, Lewis E.
    Merrill, Janette K.
    Wollins, Dana S.
    Blanke, Charles D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : 1803 - +